Fig. 2: Tumor subtyping and CCCA in patients from PALLET. | npj Breast Cancer

Fig. 2: Tumor subtyping and CCCA in patients from PALLET.

From: Effect of cross-platform gene-expression, computational methods on breast cancer subtyping in PALOMA-2 and PALLET studies

Fig. 2

a Pie chart of subtype distributions by the RNAseq-AIMS and RNAseq-PAM50.sgMd.TC subtyping methods for PALLET samples. b Odds ratios and 95% CIs for non-CCCA by breast cancer RNAseq-AIMS and RNAseq-PAM50.sgMd.TC subtype in PALLET. LET letrozole, n number of patients in the subtype treatment group, PAL palbociclib.

Back to article page